Thanks. I thought IMDS was in business to obtain FDA approval in order to sell their one product, the CTLM. Who cares if the stock goes from .0004 to .0007. How does that help women with breast cancer?
IMDS is no closer to FDA approval now than they were in 2009, or 1999 for that matter.
Question for the board. Where can a woman go TODAY in the US to get a CTLM scan at one of IMDS secret clinical sites? Surely there are thousands of women who would welcome the opportunity? One would think IMDS would be shouting that from the rooftop, instead of keeping their clinical sites hidden.